KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Receivables: 2009-2025

Historic Receivables for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $748.3 million.

  • Charles River Laboratories International's Receivables fell 3.83% to $748.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 billion, marking a year-over-year decrease of 4.49%. This contributed to the annual value of $739.2 million for FY2024, which is 8.30% down from last year.
  • Charles River Laboratories International's Receivables amounted to $748.3 million in Q3 2025, which was down 4.12% from $780.4 million recorded in Q2 2025.
  • Over the past 5 years, Charles River Laboratories International's Receivables peaked at $820.5 million during Q3 2023, and registered a low of $617.8 million during Q1 2021.
  • Its 3-year average for Receivables is $788.1 million, with a median of $787.2 million in 2024.
  • Its Receivables has fluctuated over the past 5 years, first increased by 21.39% in 2021, then fell by 8.30% in 2024.
  • Quarterly analysis of 5 years shows Charles River Laboratories International's Receivables stood at $657.6 million in 2021, then rose by 16.14% to $763.7 million in 2022, then increased by 5.56% to $806.1 million in 2023, then fell by 8.30% to $739.2 million in 2024, then declined by 3.83% to $748.3 million in 2025.
  • Its Receivables stands at $748.3 million for Q3 2025, versus $780.4 million for Q2 2025 and $772.9 million for Q1 2025.